Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 7, 2019
Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis
Rebecca Trachtman, Elizabeth Murray, Cindy M Wang, et al.
Clinical Pharmacology in Drug Development
|
October 26, 2022
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants
Tong Zhu, Sylvester Pawlak, Sima S Toussi, et al.
Clinical Rheumatology
|
September 18, 2014
A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors
Heather M Walters, Nancy Pan, Thomas J A Lehman, et al.
Clinical and Translational Science
|
July 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2022
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, et al.
Infectious Diseases and Therapy
|
May 7, 2026
Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review
Kashmira Date, Kyle Fowler, Mary Lynn Baniecki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19
Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.
Clinical Pharmacology and Therapeutics
|
June 9, 2022
Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development
Ravi Shankar P Singh, Gregory S Walker, Eugene P Kadar, et al.
Clinical Pharmacology and Therapeutics
|
April 7, 2022
Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2026
Safety and Pharmacokinetics of the RSV Fusion Inhibitor Sisunatovir Across Two Early-phase Studies in Infants and Children With RSV Lower Respiratory Tract Infection
Sima S Toussi, Cristina Calvo, Brett Haumann, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 7, 2019
Procalcitonin Differs in Children With Infection and Children With Disease Flares in Juvenile Idiopathic Arthritis
Rebecca Trachtman, Elizabeth Murray, Cindy M Wang, et al.
Clinical Pharmacology in Drug Development
|
October 26, 2022
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants
Tong Zhu, Sylvester Pawlak, Sima S Toussi, et al.
Clinical Rheumatology
|
September 18, 2014
A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors
Heather M Walters, Nancy Pan, Thomas J A Lehman, et al.
Clinical and Translational Science
|
July 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2022
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, et al.
Infectious Diseases and Therapy
|
May 7, 2026
Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review
Kashmira Date, Kyle Fowler, Mary Lynn Baniecki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 1, 2024
Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19
Mahta Mortezavi, Abigail Sloan, Ravi Shankar P Singh, et al.
Clinical Pharmacology and Therapeutics
|
June 9, 2022
Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development
Ravi Shankar P Singh, Gregory S Walker, Eugene P Kadar, et al.
Clinical Pharmacology and Therapeutics
|
April 7, 2022
Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2026
Safety and Pharmacokinetics of the RSV Fusion Inhibitor Sisunatovir Across Two Early-phase Studies in Infants and Children With RSV Lower Respiratory Tract Infection
Sima S Toussi, Cristina Calvo, Brett Haumann, et al.
Page
of 3